The epidemiology of known vector-borne pathogens is changing as common vectors move to new locations. Scientists seek novel strategies for mitigating public health risks and healthcare system burdens.
Viral vectors are indispensable tools for advancing gene therapy discovery and development. As researchers progress towards clinically relevant processes, scaling up production and clarification of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback